Various intensity of Proteus mirabilis-induced crystallization resulting from the changes in the mineral composition of urine

• Authors: Agnieszka Torzewska , Antoni Różalski
• Languages of publication: EN

Abstracts

EN

Infectious urolithiasis is a result of recurrent and chronic urinary tract infections caused by urease-positive bacteria, especially Proteus mirabilis. The main role in the development of this kind of stones is played by bacterial factors such as urease and extracellular polysaccharides, but urinary tract environment also contributes to this process. We used an in vitro model to establish how the changes in the basic minerals concentrations affect the intensity of crystallization which occurs in urine. In each experiment crystallization was induced by an addition of P. mirabilis to artificial urine with a precisely defined chemical composition. Crystallization intensity was determined using the spectrophotometric microdilution method and the chemical composition of formed crystals was established by atomic absorption spectroscopy and colorimetric methods. Increasing the concentration of all crystals forming ions such as Mg2+, Ca2+ and phosphate strongly intensified the process of crystallization, whereas reducing the amount of these components below the proper physiological concentration did not affect its intensity. The inhibitory influence of citrate on calcium and magnesium phosphate crystallization and competitive actions of calcium and oxalate ions on struvite crystals formation were not confirmed. In the case of infectious stones the chemical composition of urine plays an important role, which creates a necessity to support the treatment by developing a model of proper diet.

Keywords

EN

Proteus mirabilis; crystallization; urinary stones; mineral composition

• Publisher: Polish Biochemical Society
• Journal: Acta Biochimica Polonica
• Year: 2015
• Volume: 62
• Issue: 1
• Pages: 127-132

Dates

published

2015

received

2014-09-02

revised

2014-11-14

accepted

2015-01-09

online

2015-02-04

Contributors

author

Agnieszka Torzewska

• Department of Immunobiology of Bacteria, Institute of Microbiology, Biotechnology and Immunology, Faculty of Biology and Environmental Protection, University of Lodz, Łódź, Poland

author

Antoni Różalski

• Department of Immunobiology of Bacteria, Institute of Microbiology, Biotechnology and Immunology, Faculty of Biology and Environmental Protection, University of Lodz, Łódź, Poland

References

• Achilles W, Schulze D, Schalk C, Rodeck G (1990) The in-vivo effect of sodium-potassium citrate on the crystal growth rate of calcium oxalate and other parameters in human urine. Urol Res 18: 1-6.
• Ames BH, Dubin DT (1960) The role of polyamines in the neutralization of bacteriophage deoxiribonucleic acid. J Biol Chem 235: 769-775.
• Ariyanto E, Sen TK, Ang HM (2014) The influence of various physico-chemical process parameters on kinetics and growth mechanism of struvite crystallisation. Adv Powder Technol 25: 682-694.
• Basavaraj RD, Biyani CS, Browning AJ, Cartledge JJ (2007) The role of urinary kidney stone inhibitors and promoters in the pathogenesis of calcium containing renal stones. EAU-EBU 5: 126-136.
• Bichler KH, Eipper E, Naber K, Braun V, Zimmermann R, Lahme S (2002) Urinary infection stones. Int J Antimicrob Agents 19: 488-498.
• Desmidt E, Ghyselbrecht K, Monballiu A, Rabaey K, Verstraete W, Meesschaert BD (2013) Factors influencing urease driven struvite precipitation. Sep Purif Technol 110: 150-157.
• Grases F, Genestar C, Conte A, March P, Costa-Bauzá A (1989) Inhibitory effect of pyrophosphate, citrate, magnesium and chondroitin sulphate in calcium oxalate urolithiasis. Br J Urol 64: 235-237.
• Griffith DP, Musher DM, Itin C (1976) Urease. The primary cause of infection-induced urinary stones. Invest Urol 13: 346-350.
• Hokama S, Toma C, Jahana M, Iwanaga M, Morozumi M, Hatano T, Ogawa Y (2000) Ascorbate conversion to oxalate in alkaline milieu and Proteus mirabilis culture. Mol Urol 4: 321-328.
• Hugosson J, Grenabo L, Hedelin H, Pettersson S, Tarfusser I (1990) How variations in the composition of urine influence urease-induced crystallization. Urol Res 18: 413-417.
• Knoll T (2010) Epidemiology, pathogenesis, and pathophysiology of urolithiasis. Eur Urol Suppl 9: 802-806.
• Knoll T, Schubert AB, Fahlenkamp D, Leusmann DB, Wendt-Nordahl G, Schubert G (2011) Urolithiasis through the ages: data on more than 200 000 urinary stone analyses. J Urol 185: 1304-1311.
• Kramer G, Klingler HC, Steiner GE (2000) Role of bacteria in the development of kidney stones. Curr Opin Urol 10: 35-38.
• Le Corre KS, Valsami-Jones E, Hobbs P, Parson SA (2005) Impact of calcium on struvite crystal size, shape and purity. J Cryst Growth 283: 514-522.
• Parmar MS (2004) Kidney stones. BMJ 328: 1420-1424.
• Prywer J, Torzewska A (2009) Bacterially induced struvite growth from synthetic urine: experimental and theoretical characterization of crystal morphology. Cryst Growth Des 9: 3538-3543.
• Rodman JS (1999) Struvite stones. Nephron 81: 50-59.
• Sayer JA, Moochhala SH, Thomas DJ (2010) The medical management of urolithiasis. Brit J Med Surg Urol 3: 87-95.
• Segma JW, Erickson SB, Wilson DM, Van der Berg CJ, Smith LB (1981) Infected renal lithiasis: results of long-term surgical and medical management. In Urolithiasis, Smith LH, ed, p 195. Plenum, New York.
• Stratful I, Scrimshaw MD, Lester JN (2001) Conditions influencing the precipitation of magnesium ammonium phosphate. Water Res 35: 4191-4199.
• Suller MT, Anthony VJ, Mathur S, Feneley RC, Greenman J, Stickler DJ (2005) Factors modulating the pH at which calcium and magnesium phosphates precipitate from human urine. Urol Res 33: 254-260.
• Takeuchi H, Ueda M, Satoh M, Yoshida O (1991) Effects of dietary calcium, magnesium and phosphorus on the formation of struvite stones in the urinary tract of rats. Urol Res 19: 305-308.
• Tavichakorntrakool R, Prasongwattana V, Sungkeeree S, Saisud P, Sribenjalux P, Pimratana C, Bovornpadungkitti S, Sriboonlue P, Thongboonkerd V (2012) Extensive characterizations of bacteria isolated from catheterized urine and stone matrices in patients with nephrolithiasis. Nephrol Dial Transplant 27: 4125-4130.
• Torzewska A, Rozalski A (2014) Inhibition of crystallization caused by Proteus mirabilis during the development of infectious urolithiasis by various phenolic substances. Microbial Res 169: 579-584.
• Torzewska A, Stączek P, Różalski A (2003) Crystallization of urine mineral components may depend on the chemical nature of Proteus endotoxin polysacchrides. J Med Microbiol 52: 471-477.
• Wang Y, Grenabo L, Hedelin H, Mclean RJ, Nickel JC, Pettersson S (1993) Citrate and urease-induced crystallization in synthetic and human urine. Urol Res 21: 109-115.
• Zanetti G, Paparella S, Trinchieri A, Prezioso D, Rocco F, Naber KG (2008) Infections and urolithiasis: current clinical evidence in prophylaxis and antibiotic therapy. Arch Ital Urol Androl 80: 5-12.